CEO Patrick Mercer emphasized three key themes for 2025: the execution of a cost-reduction program completed in Q4 2024, stabilization of the business particularly in the glaucoma segment, and the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results